AptaBio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	38,128	25,016	1,989
Short-Term Investments	6,000	19,000	15,026
Trading Asset Securities	4,775	8,869	-
Cash & Short-Term Investments	48,902	52,885	17,015
Cash Growth	187.41%	210.81%	-
Other Receivables	160.53	366.31	224.46
Receivables	2,536	2,659	3,047
Prepaid Expenses	152.31	176.31	88.23
Other Current Assets	5,924	1,754	268.93
Total Current Assets	57,515	57,474	20,419
Property, Plant & Equipment	4,948	5,129	5,848
Long-Term Investments	19,688	23,779	27,885
Other Intangible Assets	49.92	61.09	37.83
Other Long-Term Assets	3,656	3,675	1,924
Total Assets	88,757	92,519	56,114
Accrued Expenses	367.76	337.19	455.54
Current Portion of Leases	159.8	131.08	109.73
Current Income Taxes Payable	-	1.48	-
Other Current Liabilities	1,490	348.2	474.75
Total Current Liabilities	2,163	817.95	1,040
Long-Term Debt	15,438	13,569	-
Long-Term Leases	184.49	233.45	256.3
Other Long-Term Liabilities	17,176	13,524	54.58
Total Liabilities	38,191	31,156	3,744
Common Stock	11,149	11,149	11,149
Additional Paid-In Capital	129,712	129,712	109,025
Retained Earnings	-91,712	-80,713	-68,473
Comprehensive Income & Other	897.91	696.38	668.63
Total Common Equity	50,047	60,845	52,370
Shareholders' Equity	50,566	61,363	52,370
Total Liabilities & Equity	88,757	92,519	56,114
Total Debt	15,782	13,934	366.03
Net Cash (Debt)	33,121	38,951	16,649
Net Cash Growth	98.93%	133.95%	-
Net Cash Per Share	1485.30	1746.78	746.98
Filing Date Shares Outstanding	22.3	22.3	22.3
Total Common Shares Outstanding	22.3	22.3	22.3
Working Capital	55,352	56,656	19,379
Book Value Per Share	2244.37	2728.60	2348.53
Tangible Book Value	49,997	60,784	52,332
Tangible Book Value Per Share	2242.13	2725.86	2346.83
Land	1,787	1,787	1,922
Buildings	3,046	3,046	3,388
Machinery	1,196	1,196	1,101

Source: S&P Capital IQ. Standard template. Financial Sources.